Form 8-K - Current report:
SEC Accession No. 0001104659-20-003255
Filing Date
2020-01-13
Accepted
2020-01-13 08:39:50
Documents
21
Period of Report
2020-01-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm203196-1_8k.htm 8-K 29298
2 EXHIBIT 10.1 tm203196d1_ex10-1.htm EX-10.1 150546
3 EXHIBIT 99.1 tm203196d1_ex99-1.htm EX-99.1 27310
4 EXHIBIT 99.2 tm203196d1_ex99-2.htm EX-99.2 27874
5 GRAPHIC tm203196d1_ex99-2img01.jpg GRAPHIC 112876
6 GRAPHIC tm203196d1_ex99-2img02.jpg GRAPHIC 427789
7 GRAPHIC tm203196d1_ex99-2img03.jpg GRAPHIC 264554
8 GRAPHIC tm203196d1_ex99-2img04.jpg GRAPHIC 209358
9 GRAPHIC tm203196d1_ex99-2img05.jpg GRAPHIC 134179
10 GRAPHIC tm203196d1_ex99-2img06.jpg GRAPHIC 174535
11 GRAPHIC tm203196d1_ex99-2img07.jpg GRAPHIC 233222
12 GRAPHIC tm203196d1_ex99-2img08.jpg GRAPHIC 254661
13 GRAPHIC tm203196d1_ex99-2img09.jpg GRAPHIC 137261
14 GRAPHIC tm203196d1_ex99-2img10.jpg GRAPHIC 141245
15 GRAPHIC tm203196d1_ex99-2img11.jpg GRAPHIC 134850
16 GRAPHIC tm203196d1_ex99-2img12.jpg GRAPHIC 129753
17 GRAPHIC tm203196d1_ex99-2img13.jpg GRAPHIC 180981
18 GRAPHIC tm203196d1_ex99-2img14.jpg GRAPHIC 166492
19 GRAPHIC tm203196d1_ex99-2img15.jpg GRAPHIC 203054
20 GRAPHIC tm203196d1_ex99-2img16.jpg GRAPHIC 100226
21 GRAPHIC tm203196d1_ex99-1img01.jpg GRAPHIC 1706
  Complete submission text file 0001104659-20-003255.txt   4378667
Mailing Address 200 BROADWAY, 3RD FLOOR NEW YORK NY 10038
Business Address 200 BROADWAY, 3RD FLOOR NEW YORK NY 10038 (212) 332-3241
Axsome Therapeutics, Inc. (Filer) CIK: 0001579428 (see all company filings)

EIN.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37635 | Film No.: 20522946
SIC: 2834 Pharmaceutical Preparations